Matt Comerford

Victhom Laboratory, Inc. is a company which owns patents in the field of orthotics and prosthetics including intellectual property used in the Power Knee. Victhom Laboratory was founded on January 11, 2002 and is headquartered in Montreal, Canada.

Founded in 1969, HSBC Securities (U.S.A.) Inc. is an SEC-registered brokerage firm and registered futures commission merchant located in New York City. The firm is a wholly-owned subsidiary of HSBC North America Holdings, Inc. and their ultimate parent is HSBC Holdings Plc. (NYSE: HBC). HSBC Securities (U.S.A.) is a member of FINRA, the NYSE and the SIPC. Their securities and annuity products are provided by registered representatives and insurance agents of HSBC Securities (U.S.A.). In California, HSBC Securities (U.S.A.) conducts insurance business as HSBC Securities Insurance Services. Insurance products are offered through insurance agents of HSBC Insurance Agency (U.S.A.) Inc., a wholly-owned subsidiary of HSBC Bank U.S.A. NA and an indirectly wholly-owned subsidiary of HSBC Holdings plc. The company also engages in investment banking underwriting, dealing and brokering of debt and equity securities and futures contracts and is a primary dealer in U.S. Government and federal agency securities.

DRM Ventures, Inc. provides investment services. The company was founded on August 24, 2009 and is headquartered in Toronto, Canada.

Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto.

Desjardins Securities, Inc. is the broker/dealer arm of the Desjardins Holding Financier, Inc., ultimately held by Le Mouvement des caisses Desjardins in Canada. Founded in 1991, the firm is headquartered in Montréal and has an additional office in Toronto. Desjardins Securities offers businesses and institutions with a complete range of securities brokerage products and services through its investment advisors and its Disnat Online Brokerage division. The firm is an approved participant on the Montreal Exchange and the Toronto Stock Exchange, as well as a participating member of the TSX Venture Exchange. In addition, Desjardins Securities is a member of both the Investment Industry Regulatory Organization of Canada (IIROC) and the Canadian Investor Protection Fund (CIPF).

Amadeus International, Inc. operates as a development stage company. It focuses on the marketing of software solutions, such as enterprise quality resource planning, and enterprise quality & compliance management. The company was founded on December 22, 2004 and is headquartered in Quebec, Canada.

PricewaterhouseCoopers LLP provides accounting services. The firm provides industry focused assurance, advisory and tax services for public, private and government clients in four areas such as corporate accountability, risk management, structuring and mergers and acquisitions and performance and process improvement. Its services include consulting, deals, risk assurance services and insolvency assignments. The company was founded on July 1, 1998 and is headquartered in Toronto, Canada.

The Prospectors & Developers Association of Canada operates as a mineral exploration and development association. The non-profit company is based in Toronto, Canada. and has subsidiaries in Canada.

Mimetogen Pharmaceuticals, Inc. develops peptidomimetic small molecule drugs against glaucoma and cancer. Its product mimic the effects of neurotrophin proteins that help to maintain the health and growth of cells and tissues found in the eye. Mimetogen provides tyrosine kinase agonists that prevent neuronal death; small molecule tyrosine kinase receptor agonists, which stimulates mucin secretion from conunctival goblet cells; and small molecule neurotrophin mimetics that rescues retinal pigment epithelial cells from oxidative stress-induced apoptosis. The company was founded by Garth Cumberlidge and H. Uri Saragovi in 2005 and is headquartered in Montreal, Canada.

Diagnomics, Inc. engages in the research and development of personalized advanced healthcare services. It offers consumer genomics solutions, analysis platform, clinical and translational research, assay development support, and bioinformatics services. The company was founded by Min Seob Lee, Stefan Gruenwald, and Dan Scholefield in 2011 and is headquartered in San Diego, CA.

Hyasynth Biologicals, Inc. manufactures natural cannabinoid compounds. It offers researchers, doctors, and patients with options in treating multiple sclerosis, epilepsy (dravet syndromes), Alzheimer’s diseases, chronic pains, inflammations, and muscular dystrophy diseases. The company was founded by Alex Campbell, Kevin Chen, Shoham Mookerjee, Sarah Choukah and Zach Wiltshire and is headquartered in Montreal, Canada.

MyGenomeBox Co., Ltd. operates as a sharing platform built upon a cloud solution that securely stores customers genome and enables them to convert their genome into useful information and to utilize 3rd party applications and services and to connect to relevant partners and individuals. It also provides cloud storage solutions. The company was founded by Shang Cheol Shin on November 11, 2015 and is headquartered in Incheon, South Korea.

Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017.